Shilpa Medicare Ltd has announced the receipt of EIR (Establishment Inspection Report) from USFDA to our both API manufacturing facilities located at Raichur, Karnataka. This inspection was carried out between 16th to 19th January, 2018. The inspection has now been closed by USFDA.
Shares of SHILPA MEDICARE LTD. was last trading in BSE at Rs.383.5 as compared to the previous close of Rs. 389.65. The total number of shares traded during the day was 600 in over 51 trades.
The stock hit an intraday high of Rs. 388.4 and intraday low of 380.1. The net turnover during the day was Rs. 230072.